Related Experiment Video
Updated: Jul 15, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid
Konstantinos Drosatos1, Despina Sanoudou, Kyriakos E Kypreos
1Department of Basic Sciences, University of Crete Medical School, Heraklion GR-71110, Greece.
Abstract:
c-Jun is a transcription factor activated by phosphorylation by the stress-activated protein kinase/c-Jun N-terminal kinase pathway in response to extracellular signals and cytokines. We show that adenovirus-mediated gene transfer of the dominant negative form of c-Jun (dn-c-Jun) in C57BL/6 mice increased greatly apoE hepatic mRNA and plasma levels, increased plasma cholesterol, triglyceride, and very low density lipoprotein levels, and resulted in the accumulation of discoidal high density lipoprotein particles. A similar but more severe phenotype was generated by overexpression of the mouse apoE in C57BL/6 mice, suggesting that dyslipidemia induced by dn-c-Jun was the result of apoE overexpression. Unexpectedly, infection of apoE(-/-) mice with adenovirus expressing dn-c-Jun reduced plasma cholesterol by 70%, suggesting that dn-c-Jun affected other genes that control plasma cholesterol levels. To identify these genes, we performed whole genome expression analysis (34,000 genes) of isolated livers from two groups of five apoE(-/-) mice, infected with adenoviruses expressing either the dn-c-Jun or the green fluorescence protein. Bioinformatic analysis and Northern blotting validation revealed that dn-c-Jun increased 40-fold the apoE mRNA and reduced by 70% the Scd-1 (stearoyl-CoA-desaturase 1) mRNA. The involvement of Scd-1 in lowering plasma cholesterol was confirmed by restoration of high cholesterol levels of apoE(-/-) mice following coinfection with adenoviruses expressing dn-c-Jun and Scd-1. In conclusion, dn-c-Jun appears to trigger two opposing events in mice that affect plasma cholesterol and triglyceride levels as follows: one results in apoE overexpression and triggers dyslipidemia and the other results in inhibition of Scd-1 and offsets dyslipidemia.
Insights
The dominant negative form of c-Jun (dn-c-Jun) triggers opposing effects on lipid metabolism. It increases apoE, leading to dyslipidemia, but also inhibits stearoyl-CoA-desaturase 1 (Scd-1), which lowers cholesterol.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- c-Jun is a transcription factor activated by stress pathways.
- Dyslipidemia is a major risk factor for cardiovascular disease.
Purpose of the Study:
- To investigate the role of dominant negative c-Jun (dn-c-Jun) in regulating lipid metabolism.
- To identify genes affected by dn-c-Jun in vivo.
Main Methods:
- Adenovirus-mediated gene transfer of dn-c-Jun in C57BL/6 and apoE(-/-) mice.
- Whole genome expression analysis of liver tissue.
- Bioinformatic analysis and Northern blotting for gene validation.
Main Results:
- dn-c-Jun overexpression in C57BL/6 mice increased apoE, leading to dyslipidemia.
- In apoE(-/-) mice, dn-c-Jun reduced plasma cholesterol by 70%.
- dn-c-Jun significantly increased apoE mRNA and decreased Scd-1 mRNA in apoE(-/-) mice.
- Inhibition of Scd-1 by dn-c-Jun was shown to lower plasma cholesterol.
Conclusions:
- dn-c-Jun has dual effects on lipid metabolism: promoting dyslipidemia via apoE and lowering cholesterol by inhibiting Scd-1.
- Scd-1 inhibition by dn-c-Jun can counteract dyslipidemia.
- These findings reveal a complex regulatory role of c-Jun in lipid homeostasis.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
General Transcription Factors
Lipid Catabolism
Co-activators and Co-repressors
Co-activators and Co-repressors

